Virus Diseases: all 927 studies

Page 3 of 10. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral InfectionsCompletedNCT03455491Phase 2Results posted
• An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT03361956Phase 2Results posted
• Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy ParticipantsCompletedNCT03343626Phase 1Results posted
• An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old AdultsCompletedNCT03334695Phase 2Results posted
• A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial VirusTerminatedNCT03333317Phase 2Results posted
• A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus InfectionCompletedNCT03332459Phase 2Results posted
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsCompletedNCT03321968Phase 3Results posted
• Ledipasvir/Sofosbuvir for Hepatitis B Virus InfectionCompletedNCT03312023Phase 2Results posted
• Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in AdultsCompletedNCT03301051Phase 3Results posted
• The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults VaccineCompletedNCT03294135Phase 4Results posted
• Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-InfectionCompletedNCT03119025Phase 1/2Results posted
• VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and AdolescentsCompletedNCT03110770Phase 2Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in ChildrenCompletedNCT03039621Phase 4Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated CirrhosisCompletedNCT02996682Phase 3Results posted
• A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naiveCompletedNCT02993250Phase 2Results posted
• A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of BelarusCompletedNCT02968173Phase 3Results posted
• Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial VirusTerminatedNCT02935673Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With InfluenzaTerminatedNCT02927431Phase 2Results posted
• Partnership for Research on Ebola VACcinationsCompletedNCT02876328Phase 2Results posted
• Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related CryoglobulinemiaCompletedNCT02825212Phase 2/3Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing RegimenCompletedNCT02822794Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver TransplantCompletedNCT02781571Phase 2Results posted
• Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerCompletedNCT02759588Phase 1/2Results posted
• Cell Mediated Immunity Against RSV and Influenza in a Human Experimental ChallengeCompletedNCT02755948Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)CompletedNCT02738138Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus InfectionCompletedNCT02723084Phase 3Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus InfectionCompletedNCT02722837Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02707952Phase 3Results posted
• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy SubjectsTerminatedNCT02696291Phase 1Results posted
• A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 InfectionCompletedNCT02640157Phase 3Results posted
• Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)TerminatedNCT02613403Phase 2Results posted
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus InfectionCompletedNCT02609659Phase 3Results posted
• Effects of Chronic Viral Infection on Immune Response to Zoster VaccinationTerminatedNCT02590068Not applicableResults posted
• A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.CompletedNCT02570126Phase 3Results posted
• A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in ChildrenCompletedNCT02548078Phase 2Results posted
• A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.CompletedNCT02545517Phase 3Results posted
• Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) InfectionCompletedNCT02534350Phase 2Results posted
• Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-FiloCompletedNCT02509494Phase 3Results posted
• A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy AdultsCompletedNCT02491463Phase 1Results posted
• Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost VaccinationCompletedNCT02485912Phase 1Results posted
• A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in AdultsCompletedNCT02485301Phase 2Results posted
• Safety, Tolerability and Clinical Effect of Danirixin in Adults With InfluenzaCompletedNCT02469298Phase 2Results posted
• A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy AdultsCompletedNCT02416453Phase 2Results posted
• Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant RecipientsCompletedNCT02351180Phase 1/2Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation SettingCompletedNCT02350569Phase 2Results posted
• Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in GuineaCompletedNCT02342171Phase 2/3Results posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02292719Phase 2Results posted
• A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm InfantsCompletedNCT02290340Phase 1Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus InfectionCompletedNCT02250807Phase 3Results posted
• Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and AdolescentsCompletedNCT02250274Phase 4Results posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated CirrhosisCompletedNCT02219477Phase 3Results posted
• Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02185794Phase 1Results posted
• A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older AdultsCompletedNCT02115815Phase 1Results posted
• A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)CompletedNCT02114385Phase 3Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without CirrhosisCompletedNCT02114177Phase 3Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and CirrhosisCompletedNCT02114151Phase 3Results posted
• Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell TransplantCompletedNCT02108522Not applicableResults posted
• Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in ChildrenCompletedNCT02072174Phase 4Results posted
• Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant GliomaActive, not recruitingNCT02062827Phase 1Results posted
• Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy SubjectsCompletedNCT02061358Phase 1Results posted
• Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus InfectionTerminatedNCT02058108Phase 3Results posted
• Chemotherapy for Relapsed Epstein Barr Virus Associated LymphomaTerminatedNCT01964755Phase 2Results posted
• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionCompletedNCT01939197Phase 2/3Results posted
• A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeCompletedNCT01854697Phase 3Results posted
• Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)CompletedNCT01839188Phase 3Results posted
• Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b ParticipantsCompletedNCT01700179Phase 1Results posted
• A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus InfectionCompletedNCT01672983Phase 2Results posted
• Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving ChemotherapyCompletedNCT01666782Phase 2Results posted
• Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) ProgramCompletedNCT01662336Results posted
• Development of Method of Fructose Identification in Urine to Detect the Viral InfectionCompletedNCT01638312Results posted
• Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant RecipientsCompletedNCT01624948Phase 4Results posted
• ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK VirusCompletedNCT01570283Phase 1/2Results posted
• Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination SchedulesCompletedNCT01562444Phase 4Results posted
• Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)CompletedNCT01553279Phase 3Results posted
• Respiratory Syncytial Virus - RSV ProtocolCompletedNCT01502072Phase 2Results posted
• Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)CompletedNCT01480258Phase 3Results posted
• Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical ConditionsCompletedNCT01466062Phase 3Results posted
• Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in ToddlersCompletedNCT01396512Phase 3Results posted
• Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot StudyCompletedNCT01353339Phase 4Results posted
• The Development of a Human Model of Respiratory Syncytial Virus InfectionCompletedNCT01349543Not applicableResults posted
• Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)CompletedNCT01341639Phase 3Results posted
• A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)CompletedNCT01340937Phase 3Results posted
• Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)CompletedNCT01337167Phase 3Results posted
• Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus InfectionCompletedNCT01308424Phase 1/2Results posted
• Collection and Testing of Respiratory SamplesCompletedNCT01302418Results posted
• A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin AmericaCompletedNCT01297504Results posted
• VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus InfectionCompletedNCT01241760Phase 3Results posted
• Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA VirusesCompletedNCT01143181Phase 3Results posted
• Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) InfectionCompletedNCT01107535Results posted
• Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01097395Phase 4Results posted
• Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian ChildrenCompletedNCT01006629Phase 2/3Results posted
• Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of ShinglesCompletedNCT00921934Results posted
• A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI RegimenCompletedNCT00749580Not applicableResults posted
• Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)CompletedNCT00711009Phase 3Results posted
• Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral InfectionTerminatedNCT00582738Phase 2Results posted
• Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus InfectionCompletedNCT00575185Phase 1/2Results posted
• Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of AgeCompletedNCT00493285Phase 1Results posted
• Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus InfectionCompletedNCT00395018Phase 3Results posted
• Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected SubjectsCompletedNCT00262522Phase 3Results posted
• Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus InfectionCompletedNCT00180674Phase 2Results posted

← Virus Diseases overview